|
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
|
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan |
Northwestern Mutual Foundation |
|
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University |
Northwestern Mutual Foundation |
|
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida |
Northwestern Mutual Foundation |
|
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia |
University of California San Francisco |
Northwestern Mutual Foundation |
|
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb |
University of Wisconsin - Madison |
Northwestern Mutual Foundation |
|
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |